Air freshener dangerous to health

December 13th, 2011|

Air fresheners which are used for clean refreshing house or car may smells sweet but very few people understand how bad air fresheners are for their health. Science has confirmed that though air freshener smells sweet but they may cause lung cancer. People with asthma or allergies may want to avoid air fresheners and other chemicals used to spread fragrant scents through their homes, and their doctors should be aware of the hazards.

No place like home, finds Indian pharma

February 7th, 2010|

In a recent reversal, operations abroad are hampering profit.

Mexico plans world-class medical research hub

December 6th, 2009|

Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research. To be called Campus Biometropolis, the city hopes the new centre will attract investment and become an "engine for the transformation" of Mexico's economy.

Avon to gain from nod to Ranbaxy’s drug

December 6th, 2009|

Ranbaxy Laboratories exclusive launch of generic anti-herpes Valtrex (valacyclovir hydrochloride) tablets in the US will help a listed Indian drug company, Hyderabad-based Avon Organics.

In healthcare, we can at best play catch-up with China

November 19th, 2009|

Dan Vasella, the chief executive of Swiss firm Novartis, which has been struggling for the last five years to secure the patent rights in India on Glivec, its therapy for a rare form of blood cancer called chronic myeloid leukemia, has spoken again on the alleged gaps in the Indian patent system.

BIG PHARMA AND BIOTECH

November 9th, 2009|

The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts.

A 360 Degree Perspective for CEOs to drive Growth, Innovation and Leadership,

October 25th, 2009|

Companies seem to be hesitating in moving ahead as they wait for further improvements in the global economy. However, Frost & Sullivan believes that the best CEOs are already planning how their businesses will take advantage of the growth opportunities presented by the rebound.

Drug MNCs look at India as a market

October 6th, 2009|

The list of drug majors scouting for a suitable buy in India is long. But this time, the attraction is: India as a market, and not merely as an inexpensive destination to source and produce products, say consultants and lawyers observing the increased merger and acquisition (M&A) activity seen in the pharmaceutical space.

Pfizer plans major push into generics

September 10th, 2009|

Pfizer Ltd, the Indian subsidiary of the world’s largest drug maker Pfizer Inc., is making an aggressive play in the Indian generics or off-patent drugs market.

Big pharma companies join outsourcing queue

August 18th, 2009|

India emerging as a big global destination for contract manufacturing, unlike R&D outsourcing

Frost & Sullivans Food & Beverage Focus 2009

July 23rd, 2009|

Growing awareness and increased investments lead to growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements sector, reveals Frost & Sullivan

Indian pharma firms swallow bitter pill in US, Europe

July 15th, 2009|

Last week, Lupin, Matrix Laboratories and Unichem Laboratories’ UK subsidiary Niche Generics figured in the list of companies under investigation by the European Commission for “knowingly delaying” the generic launch of a cardiovascular drug, Perindopril, by teaming with the innovator of the drug, Laboratories Servier. The European Commission said it would probe anti-trust violations against these manufacturers.

EU Raps Big Pharma, Indian copycat kings boosted

July 8th, 2009|

In a shot in the arm for Indian drugmakers, the trade and competition commissions of the European Union (EU), the US, and Italy are cracking down on unfair competition practices adopted by multinational pharma companies to extend their monopoly and delay low-cost generics from reaching consumers.

Pharmas biggest boost comes from removal of fringe benefit tax news

July 7th, 2009|

Among all industries, the pharmaceutical sector will perhaps benefit the most from the withdrawal of the ill-conceived fringe benefit tax, as it spends a minimum of 15 per cent of its turnover on medical representatives and sales promotion. 

US study wants India to allow frivolous patenting

June 28th, 2009|

Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in their favour.

Big Pharma gets gold star on climate change scorecard

June 10th, 2009|

Pharmaceutical sector striding forward on greenhouse gas emissions.

Indian pharma players to benefit from generic drugs in US

May 21st, 2009|

Increased use of generic drugs helped the US healthcare system save billions of dollars over the last decade.

Pharma sector hails UPA win, expects continuity of eco reforms

May 17th, 2009|

The Indian pharma industry welcomed the UPA's return to power with a decisive mandate saying it would enable formation of a stable government and carry forward economic reforms, while raising hopes that the Centre would frame policies that will support the sector.

Sun Pharma gets CNBC-TV18 & DHL’s ‘Outstanding Exporter 2008-09’ award

April 28th, 2009|

Sun Pharmaceutical, a Mumbai-based Rs 3350 crore pharmaceutical giant and India's fastest growing international speciality pharma company, has received award in Outstanding Pharmaceuticals, Healthcare & Life Sciences category at the 3rd DHL and CNBC-TV18 International Trade Awards 2008-2009. These awards recognise the efforts of organisations and individuals who have driven India's growth engine in global trade and taken 'Brand India' to the world.

Pharma welcomes UK taxation pledge

April 22nd, 2009|

The UK government budget delivered in the gloom of the recession has provided good news for the industry, according to its leaders.